| Literature DB >> 26540270 |
Jincai Hou1,2, Jianhua Fu1,2, Dan Li1,2, Xiao Han1,2, Lei Li1,2, Wenting Song1,2, Mingjiang Yao1,2, Jianxun Liu1,2.
Abstract
Myocardial ischemia is a pathological state of heart with reduced blood flow to heart and abnormal myocardial energy metabolism. This disease occurs commonly in middle aged and elderly people. Several studies have indicated that the rat was an appropriate animal model used to study myocardial ischemia. In this study, in order to gain insights into the pathogenesis of myocardial ischemia, we sequenced the transcriptomes of three normal rats as control and the same number of myocardial ischemia rats. We sequenced the genomes of 6 rats, including 3 cases (myocardial ischemia) and 3 controls using Illumina HiSeq 2000. Then we calculated the gene expression values and identified differentially expressed genes based on reads per kilobase transcriptome per million (RPKM). Meanwhile we performed a GO enrichment analysis and predicted novel transcripts. In our study, we found that 707 genes were up-regulated and 21 genes were down-regulated in myocardial ischemia rats by at least 2-fold compared with controls. By the distribution of reads and the annotation of reference genes, we found 1,703 and 1,552 novel transcripts in cases and controls, respectively. At the same time, we refined the structure of 9,587 genes in controls and 10,301 in cases. According to the results of GO term and pathway analysis of differentially expressed genes, we found that the immune response, stimulus response, response to stress and some diseases may be associated with myocardial ischemia. Since many diseases, especially immune diseases, are associated with myocardial ischemia, we should pay more attention to the complications which might result from myocardial ischemia.Entities:
Mesh:
Year: 2015 PMID: 26540270 PMCID: PMC4634849 DOI: 10.1371/journal.pone.0141915
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Statistics of reads mapped to reference genome.
| Case | Control | |
|---|---|---|
| Total reads | 27,488,888(100%) | 27,488,888(100%) |
| Mapped reads | 20,981,954(76.33%) | 21,313,098(77.53%) |
| Unique match reads | 17,796,433(64.74%) | 18,279,163(66.50%) |
| Unmapped reads | 6,506,934(23.67%) | 6,175,790(22.47%) |
Statics of reads mapped to reference genes.
| Case | Control | |
|---|---|---|
| Total reads | 27,488,888(100%) | 27,488,888(100%) |
| Mapped reads | 11,580,711(42.13%) | 11,689,116(42.52%) |
| Unique match reads | 11,042,257(40.17%) | 11,194,176(40.72%) |
| Unmapped reads | 15,908,177(57.87%) | 15,799,772(57.48%) |
The statics of genes expression.
| The number of genes | ||
|---|---|---|
| Case | Control | |
| Total genes | 15,116 | 14,884 |
| Genes only expressed in case | 872 | - |
| Genes only expressed in control | - | 639 |
| DEGs which were up-regulated | 707 | - |
| DEGs which were down-regulated | 21 | - |
Top ten up- regulated and down-regulated genes in myocardial ischemia.
| Ensembl gene ID | Gene symbol | Description | Chr | Start | End | Log2 Ratio(Case FPKM/Control FPKM) | Up or Down |
|---|---|---|---|---|---|---|---|
| ENSROG00000002792 | Cxcl2 | Chemokine(C-X-C motif) ligand 2 | 14 | 18,640,312 | 18,642,357 | 12.3797 | Up |
| ENSRNOG00000038831 | _ | _ | _ | _ | _ | 12.1845 | Up |
| ENSRNOG00000025980 | Gm14137 | Predicted gene 14137 | 3 | 117,533,191 | 117,533,736 | 11.8366 | Up |
| ENSRNOG00000024399 | Cd300a | CD300A antigen | 10 | 103,094,716 | 103,107,421 | 11.5540 | Up |
| ENSRNOG00000005118 | _ | _ | _ | _ | _ | 11.0079 | Up |
| ENSRNOG00000003666 | IGJ | Immunoglobulin joining chain | 14 | 21.087.060 | 21,093,606 | 10.3672 | Up |
| ENSRNOG00000026430 | Trim58 | Tripartite motif-containing 58 | 10 | 44,076,388 | 44,087,527 | 10.3524 | Up |
| ENSRNOG00000031687 | _ | _ | _ | _ | _ | 10.1799 | Up |
| ENSRNOG00000010278 | Il6 | Interleukin 6 | 4 | 3,095,536 | 3,100,112 | 10.1410 | Up |
| ENSRNOG00000020355 | Twist2 | Twist basic helix-loop-helix transcription factor 2 | 9 | 98,599,201 | 98,642,827 | 9.9621 | Up |
| ENSRNOG00000030281 | Klk10 | Kallikrein related-peptidase 10 | 1 | 100,787,665 | 100,791,042 | -10.4352 | Down |
| ENSRNOG00000026522 | _ | _ | _ | _ | _ | -9.4750 | Down |
| ENSRNOG00000037299 | Smpd5 | Sphingomyelin phosphodiesterase 5 | 7 | 117,337,460 | 117,339,998 | -9.1895 | Down |
| ENSRNOG00000009204 | Il17re | Interleukin 17 receptor | 4 | 208,711,257 | 208,723,904 | -8.9065 | Down |
| ENSRNOG00000020936 | Nradd | Neurotrophin receptor associated death domain | 8 | 118,231,775 | 118,234,748 | -3.2271 | Down |
| ENSRNOG00000042717 | RGD1566380 | Uncharacterized protein LOC365871 | 2 | 217,478,839 | 217,482,049 | -2.3812 | Down |
| ENSRNOG00000006104 | Tg | Thyroglobulin | 7 | 107,399,165 | 107,585,123 | -2.2522 | Down |
| ENSRNOG00000011861 | Aadat | Aminoadipate aminotransferase | 16 | 32,665,787 | 32,702,406 | -1.9385 | Down |
| ENSRNOG00000033844 | Bex1 | Brain expressed,Xlinked 1 | 1 | 117,724,202 | 117,725,601 | -1.8810 | Down |
| ENSRNOG00000012223 | _ | _ | 9 | 59,774,372 | 60,016,299 | -1.7161 | Down |
Top ten of Enriched Gene Ontology(GO) terms associated with the differentially expressed genes.
| GO term id | GO term name | P value |
|---|---|---|
| GO:0002376 | Immune system process(BP) | 6.59E-21 |
| GO:0044421 | Extracellular region part(CC) | 2.52E-19 |
| GO:0005576 | Extracellular region(CC) | 1.98E-18 |
| GO:0065007 | Biological regulation(BP) | 7.72E-16 |
| GO:0050789 | Regulation of biological process(BP) | 2.83E-14 |
| GO:0031012 | Extracellualr matrix(CC) | 1.13E-13 |
| GO:0023033 | Signaling pathway(BP) | 1.22E-13 |
| GO:0050794 | Regulation of cellular process(BP) | 7.13E-13 |
| GO:0051239 | Regulation of multicellular organismal process | 1.17E-12 |
| GO:0050896 | Response to stimulus(BP) | 1.47E-12 |
Top ten of pathways associated with the differentially expressed genes.
| Pathway | P value |
|---|---|
| Malaria | 1.11E-13 |
| African trypanosomiasis | 8.27E-11 |
| Chagas disease(American trypanosomiasis | 2.79E-10 |
| Rheumatoid arthritis | 7.19E-10 |
| Osteoclast differentiation | 1.33E-09 |
| Cytokine-cytokine receptor interaction | 2.99E-08 |
| Leishmaniasis | 4.74E-08 |
| Cell adhesion molecules(CAMs) | 1.60E-07 |
| ECM-receptor interaction | 2.66E-06 |
| Complement and coagulation cascades | 4.34E-06 |